China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II Clinical Study of HZ-H08905 on Efficacy and Safety in Patients with Relapsed and/or Refractory Non-Hodgkin Lymphoma (NHL)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132942
Registration Time: 2026/09/20
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=292474
Published by HT Digital Content Services with permission from Health Daily Digest....